WHAT IS ALKALINE PHOSPHATASE (ALP)?
If your blood test shows "Alkaline Phosphatase," "ALP," or "Alk Phos":
- This measures an enzyme produced by the liver, bile ducts, bones, and other tissues
- High ALP most often reflects liver/bile duct disease or increased bone turnover — the pattern with other markers determines which
- Low ALP is less common but can indicate malnutrition, hypothyroidism, zinc deficiency, or (rarely) hypophosphatasia
- ALP alone rarely gives a complete picture — GGT, ALT, and AST are nearly always needed alongside it
4 things to know about ALP:
- ALP has three main sources — liver, bile ducts, and bone. The pattern with other markers (especially GGT) determines which is responsible
- GGT is the single most important companion test — elevated GGT + elevated ALP = liver/bile duct source; normal GGT + elevated ALP = bone or physiological
- High ALP is normal in children and late pregnancy — values up to 350–400 U/L in growing children and 2–3× normal in the third trimester are expected
- Mild elevations (< 1.5× ULN) are extremely common — often explained by vitamin D deficiency, bone activity, medications, or lab variation rather than liver disease
Quick interpretation:
| Result | Usually means |
|---|---|
| Below 44 U/L | Low — see low ALP section below |
| 44–121 U/L | Normal range (LabCorp adult reference) |
| 122–180 U/L (1–1.5× ULN) | Mildly elevated — check GGT, ALT, AST alongside; many benign explanations |
| 181–250 U/L (1.5–2× ULN) | Moderately elevated — evaluation recommended |
| Above 250 U/L (> 2× ULN) | Clearly elevated — likely clinically significant |
| Above 500 U/L (> 4× ULN) | Markedly elevated — primary biliary cholangitis, Paget's disease, bone metastases among likely causes |
"MY ALP IS X" — INDIVIDUAL VALUE LOOKUP
Reference range: approximately 44–121 U/L (LabCorp adult); 39–117 U/L (Quest adult). Always compare to your own lab’s printed range.
Why context matters — two people, same ALP of 150:
- Person A: 45-year-old woman, no symptoms, GGT normal, ALT normal, recently started a new medication → Likely medication effect or mild bone activity. Recheck in 3–6 months.
- Person B: 52-year-old man, fatigue, mild right-upper-quadrant discomfort, GGT elevated, ALT mildly elevated → Liver or bile duct source likely. Ultrasound and hepatology referral appropriate.
Same number. Completely different clinical picture.
| My ALP is... | What it usually means | Next step |
|---|---|---|
| My ALP is 80 U/L | Normal; mid-range for most adult labs | No action needed |
| My ALP is 100 U/L | Normal | No action needed |
| My ALP is 120 U/L | At or near the upper boundary of normal at most labs | If GGT, ALT, AST are normal, no immediate workup usually needed |
| My ALP is 130 U/L | Mildly above the LabCorp upper limit (121 U/L). Common in mild bone activity, growing adolescents, or mild medication effect | Check GGT — elevated GGT points to liver/bile ducts; normal GGT points to bone or physiological cause |
| My ALP is 150 U/L | Mildly elevated at most labs (~1.25× ULN). The most common level seen on routine CMP flagging | Check GGT, ALT, AST; review vitamin D, medications, bone activity |
| My ALP is 180 U/L | Mildly to moderately elevated (~1.5× ULN) | GGT + ALT + AST + vitamin D are the standard initial panel |
| My ALP is 200 U/L | Moderately elevated (~1.7× ULN). At this level, a benign explanation is possible but less certain | Clinically relevant; source identification is the priority |
| My ALP is 250 U/L | Clearly elevated (~2× ULN). Less likely to be explained by minor causes at this level | Full liver panel + imaging usually appropriate |
| My ALP is 300 U/L | Significantly elevated (~2.5× ULN). Consider significant hepatobiliary or bone pathology | Liver ultrasound; hepatology/gastroenterology evaluation |
| My ALP is 400 U/L | Markedly elevated (~3.3× ULN). Paget’s disease, primary biliary cholangitis, or metastases are common at this level | Specialist evaluation; GGT and bone markers help direct the workup |
| Above 500 U/L | Very high. Most commonly Paget’s disease (bone), primary biliary cholangitis, or liver metastases in adults | Specialist evaluation needed |
When should I be concerned?
| ALP level | When should I be concerned? | Notes |
|---|---|---|
| < 1.5× ULN (~< 180 U/L) | Usually not urgently | Many benign explanations; context and trend matter more than the absolute value |
| 1.5–2× ULN (180–240 U/L) | Worth evaluation | Source identification (liver vs bone) is the priority |
| 2–3× ULN (240–360 U/L) | Yes, evaluation expected | Specialist input likely helpful if persistent |
| > 3× ULN (> 360 U/L) | Yes | Hepatology, gastroenterology, or rheumatology depending on context |
HOW TO READ AN ELEVATED ALP — DECISION PATHWAY
| Step | Question | If YES → | If NO → |
|---|---|---|---|
| 1 | Is ALP above the lab’s upper limit? | Go to Step 2 | Normal result |
| 2 | Is GGT also elevated? | Liver or bile duct source — go to Step 3 | Bone or physiological source — go to Step 6 |
| 3 | Is ALT or AST elevated? | Hepatocellular disease (hepatitis, fatty liver, cirrhosis) | Cholestatic disease (bile duct obstruction, PBC, PSC) — go to Step 4 |
| 4 | Is there bile duct dilation on ultrasound? | Mechanical obstruction (gallstone, stricture) | Intrinsic biliary disease (PBC, PSC) — check AMA |
| 5 | Is ALP > 3× ULN with symptoms (jaundice, pruritus, fatigue)? | Hepatology referral | Monitor with repeat labs in 3–6 months |
| 6 | Is the patient a child, adolescent, or in 3rd-trimester pregnancy? | Normal physiological elevation — no workup needed | Go to Step 7 |
| 7 | Is 25-OH Vitamin D low? | Vitamin D deficiency/osteomalacia — supplement and recheck | Go to Step 8 |
| 8 | Is this an older adult with bone pain, skull enlargement, or hearing changes? | Consider Paget’s disease — bone scan or X-ray | Consider bone metastases if cancer history; fracture if recent injury |
THE MOST IMPORTANT QUESTION: LIVER OR BONE?
When ALP is elevated, the single most important next question is: where is it coming from? The management is completely different depending on the source.
The ALP + GGT pattern — the key diagnostic shortcut:
| ALP | GGT | ALT/AST | Most likely source |
|---|---|---|---|
| High | High | High | Liver disease (hepatitis, fatty liver, cirrhosis, drug toxicity) |
| High | High | Normal or mildly elevated | Bile duct obstruction (gallstones, stricture, cholangitis, PBC, PSC) |
| High | Normal | Normal | Bone (Paget's disease, healing fracture, bone metastases, osteomalacia) |
| High | Normal | Normal | Physiological: pregnancy (3rd trimester), childhood/adolescent growth, post-meal (certain blood types) |
| High | Mildly elevated | Normal | Less clear; consider both bone and biliary causes |
| Normal | High | Normal or elevated | Liver source (alcohol, medications, fatty liver) — GGT rises faster than ALP with alcohol exposure |
Why GGT is such a useful distinguishing marker: GGT (gamma-glutamyl transferase) is not produced in significant amounts by bone. So if ALP is elevated and GGT is also elevated, the excess ALP is almost certainly coming from the liver or bile ducts, not bone. If ALP is elevated and GGT is normal, bone is the most likely source, since bone disorders elevate ALP without affecting GGT.
The 5-nucleotidase (5-NT) alternative: If GGT testing isn't available or if the result is ambiguous, 5-nucleotidase is another liver-specific enzyme that, like GGT, is not elevated in bone disease. A positive 5-NT alongside elevated ALP confirms hepatic origin.
ALP ISOENZYMES — WHEN IS FRACTIONATION USED?
ALP exists in multiple distinct isoforms produced by different tissues. In most clinical situations, checking GGT alongside ALP is sufficient to determine whether the source is hepatic or bone. ALP isoenzyme fractionation (which directly measures the proportion from liver, bone, intestine, and placenta) is reserved for situations where the source remains unclear after GGT and clinical context.
| Isoenzyme | Source | When it rises |
|---|---|---|
| Liver isoenzyme | Hepatocytes, bile duct epithelium | Liver disease, bile duct obstruction, cholestasis |
| Bone isoenzyme (BAP) | Osteoblasts (bone-forming cells) | Paget’s disease, fracture healing, bone metastases, osteomalacia, hyperparathyroidism, childhood growth |
| Placental isoenzyme | Placenta | Third trimester pregnancy; also a tumor marker in some cancers (Regan isoenzyme) |
| Intestinal isoenzyme | Small intestinal mucosa | Post-meal, particularly in blood types B and O; occasionally elevated in liver cirrhosis |
| Kidney isoenzyme | Kidney tubules | Rarely elevated to clinically meaningful levels in isolation |
Bone-specific ALP (BAP): This specific assay, which measures only the bone isoform, is used in monitoring metabolic bone disease treatment (Paget’s, osteoporosis, bone metastases) rather than as a primary diagnostic test. A rising BAP during treatment for Paget’s disease indicates inadequate disease control; a falling BAP indicates treatment response.
When isoenzyme testing is ordered: Typically considered when GGT is unexpectedly normal despite elevated ALP and the clinical cause isn’t clear from context, or when precise quantification of bone ALP is needed for monitoring a known bone disorder.
WHAT DOES HIGH ALP MEAN?
An elevated ALP means that one or more tissues producing this enzyme are under increased activity or stress. The degree of elevation roughly guides the differential.
Liver and bile duct causes:
| Condition | Typical ALP elevation | Key additional features |
|---|---|---|
| Non-alcoholic fatty liver disease (NAFLD) | Mild (1–2× ULN) | Usually normal or mildly elevated ALT; extremely common |
| Hepatitis (viral, autoimmune) | Mild to moderate | Elevated ALT often more prominent than ALP |
| Alcohol-related liver disease | Mild to moderate | GGT typically elevated (often more than ALP); history of alcohol use. Importantly: alcohol characteristically raises GGT far more than ALP — a GGT that is disproportionately elevated compared to ALP (e.g., GGT 3× ULN with ALP only 1.5× ULN) is a classic pattern suggesting alcohol as the primary driver rather than a biliary cause |
| Drug-induced liver injury (DILI) | Mild to moderate to high depending on agent and pattern | Medication history critical. DILI can present as a hepatocellular pattern (ALT/AST dominant), a cholestatic pattern (ALP/GGT dominant), or a mixed pattern. Cholestatic DILI — where ALP and GGT rise out of proportion to ALT/AST — is commonly caused by amoxicillin-clavulanate, fluoroquinolones, macrolide antibiotics, hormonal contraceptives, anabolic steroids, phenytoin, and carbamazepine. The temporal relationship between starting a medication and the ALP rise is the key diagnostic clue |
| Bile duct obstruction (gallstones, stricture) | Moderate to high | GGT elevated; bilirubin may also be elevated; imaging findings |
| Primary biliary cholangitis (PBC) | Moderate to very high | Positive AMA antibody; GGT elevated; female predominance. Classic presentation: middle-aged woman with fatigue, pruritus, and ALP elevated out of proportion to ALT/AST |
| Primary sclerosing cholangitis (PSC) | Moderate to high | GGT elevated; associated with inflammatory bowel disease |
| Liver metastases | High to very high | Often markedly elevated; cancer history; imaging findings |
| Intrahepatic cholestasis | Moderate to high | Various causes; GGT elevated |
Bone causes:
| Condition | Typical ALP elevation | Key features |
|---|---|---|
| Paget’s disease of bone | High to very high (sometimes >1,000 U/L) | Normal GGT; normal ALT/AST; bone pain or deformity; elevated bone-specific ALP and urinary bone markers. Often found incidentally on routine bloodwork — many patients are asymptomatic. Most commonly affects pelvis, skull, long bones, and vertebrae. Bisphosphonate treatment typically reduces ALP substantially within 3–6 months |
| Healing fracture | Mild to moderate | Recent fracture history; ALP peaks around 2–4 weeks post-fracture |
| Vitamin D deficiency / osteomalacia | Mild to moderate | Low 25-OH vitamin D; low calcium or phosphate; bone pain |
| Bone metastases | Moderate to very high | Cancer history; normal GGT; bone scan findings |
| Rickets | High (in children) | Children only; calcium/phosphate/vitamin D abnormalities |
Physiological elevations (normal):
- Children and adolescents: ALP can be 3–5× the adult upper limit during growth spurts — entirely normal, driven by bone formation
- Pregnancy: ALP rises 2–3× normal in the third trimester due to placental ALP production — normal finding
- After a fatty meal: Transient rise in ALP from intestinal origin in people with blood types B or O — resolves within hours; a fasting specimen eliminates this artifact
WHAT DOES LOW ALP MEAN?
Low ALP (below approximately 44 U/L) is less common than elevated ALP but can be clinically meaningful. Most low ALP results are mild and explained by nutritional status.
Common causes of low ALP:
| Cause | Mechanism | Key features |
|---|---|---|
| Zinc deficiency | Zinc is a cofactor for ALP enzyme activity; deficiency directly reduces ALP | Low serum zinc; dietary history |
| Magnesium deficiency | Similarly serves as a cofactor for ALP | Low serum magnesium |
| Hypothyroidism | Thyroid hormone stimulates bone turnover and ALP production; low thyroid → lower ALP | Elevated TSH; classic hypothyroid symptoms |
| Malnutrition / protein deficiency | Insufficient substrate for enzyme production | Low albumin; dietary history |
| Vitamin B12 deficiency / pernicious anemia | Mechanism not fully established; association well-documented | Low B12; macrocytic anemia |
| Celiac disease | Malabsorption of zinc and other ALP cofactors | Anti-TTG antibodies; response to gluten-free diet. Important nuance: celiac disease can also cause elevated ALP (not just low) through secondary liver involvement (“celiac hepatitis” or celiac-related elevation of liver enzymes). In a patient with unexplained elevated transaminases or ALP, celiac disease is worth screening for — it often resolves on a gluten-free diet without any other liver-specific treatment |
| Wilson's disease | Copper accumulation interferes with ALP; low ALP in Wilson's with acute liver failure is a recognized clinical pattern | Kayser-Fleischer rings; elevated urinary copper; liver disease in young patient |
| Cardiac surgery with bypass | Acute hemodilution and hypothermia can transiently lower ALP | Post-surgical context |
| Hypophosphatasia (HPP) | Rare genetic disorder causing loss-of-function mutations in the tissue-nonspecific ALP gene | Extremely low ALP (sometimes near zero or undetectable); poor bone mineralization; premature tooth loss (including before age 5 in childhood forms); stress fractures; rickets-like presentation. Severity ranges from the lethal perinatal form to the mild odontohypophosphatasia form affecting only teeth. Asfotase alfa (enzyme replacement therapy) is approved for severe pediatric forms |
The Wilson's disease alert: A very low ALP in a young patient with acute liver failure is a recognized and important clinical pattern. In most forms of liver failure, ALP rises because liver cells are under stress. In Wilson's disease-related acute liver failure, however, ALP paradoxically falls — possibly because copper accumulation interferes with ALP synthesis. A very low ALP in a jaundiced young patient with acute liver failure warrants Wilson's disease evaluation even though most other causes of liver failure produce elevated ALP.
ALP ACROSS DIFFERENT POPULATIONS
Because ALP varies significantly by age, sex, and physiological state, the same absolute value can be normal in one person and pathological in another.
| Population | Normal ALP behavior | Clinical note |
|---|---|---|
| Children (0–12 years) | 100–350 U/L; varies by age and growth phase | Bone growth is the dominant source; values well above the adult range are normal |
| Adolescents (puberty) | May reach 400–500 U/L during peak growth | Highest during growth spurts; GGT and ALT are normal, confirming bone origin |
| Adults (18–50) | 44–121 U/L (typical LabCorp range) | Stable range; elevations more likely pathological |
| Adults (> 50) | Slightly higher in women post-menopause | Estrogen normally suppresses bone ALP; after menopause, a mild rise is common |
| Pregnancy (1st–2nd trimester) | Often near or at upper limit of normal | Beginning to rise from placental and bone contributions |
| Pregnancy (3rd trimester) | 2–3× ULN; can reach 200–300 U/L | Placental ALP; entirely normal; does not indicate liver disease |
| Postpartum | Returns to normal within 4–8 weeks | Placental and bone ALP normalize after delivery |
ALP in pregnancy — important clinical context: Placental ALP is a distinct isoform produced by placental tissue and not a sign of liver disease. An ALP of 200–350 U/L in the third trimester with normal ALT, AST, and GGT is expected and does not require investigation. However, if ALP is very markedly elevated in pregnancy (> 4× ULN) or accompanied by elevated ALT, AST, bilirubin, or GGT, intrahepatic cholestasis of pregnancy (ICP) and HELLP syndrome should be considered — these are genuinely serious conditions that require prompt evaluation.
ALP and thyroid disease: Thyroid hormone stimulates bone turnover and ALP production. Both directions of thyroid dysfunction can affect ALP:
- Hyperthyroidism can mildly raise ALP through accelerated bone turnover (increased bone formation and resorption both release ALP)
- Hypothyroidism can lower ALP for the same reason — reduced thyroid hormone reduces bone turnover and ALP production
This is why TSH is included in the related biomarkers and why thyroid status is worth checking when ALP is persistently low without another obvious explanation.
WHAT CHANGES ALP QUICKLY?
| Raises ALP | Lowers ALP |
|---|---|
| Bile duct obstruction (acute onset) | Initiating zinc supplementation |
| Starting a hepatotoxic medication | Treating hypothyroidism |
| Bone fracture (peaks 2–4 weeks post-fracture) | Gluten-free diet in celiac disease |
| Starting corticosteroids (transient) | Correcting B12 or magnesium deficiency |
| Rapid bone metastases progression |
Medications that commonly raise ALP: Corticosteroids, phenytoin and other antiseizure medications, hormonal contraceptives, some antibiotics, NSAIDs with chronic use, allopurinol, proton pump inhibitors (mild effect), and certain herbal supplements (kava, comfrey, pennyroyal). Statin medications can occasionally raise liver enzymes including ALP, though this is uncommon.
NEXT TESTS AFTER ELEVATED ALP
Step 1 — Determine the source (liver vs bone):
| Test | Purpose |
|---|---|
| GGT | Liver/bile duct marker — elevated with liver/biliary cause, normal with bone cause |
| ALT and AST | Liver cell injury markers — elevated in hepatitis, normal in pure bile duct or bone disease |
| 5-nucleotidase (5-NT) | Alternative to GGT for confirming hepatic origin if GGT result is ambiguous |
Step 2 — If liver/bile duct source confirmed (GGT elevated):
| Test | Purpose |
|---|---|
| Liver ultrasound | First-line imaging; detects bile duct dilation, gallstones, fatty liver, masses |
| Bilirubin (direct and total) | Elevated in obstructive or hepatocellular jaundice |
| Viral hepatitis panel (HBsAg, anti-HCV) | Hepatitis B and C screening |
| Anti-mitochondrial antibody (AMA) | Screening for primary biliary cholangitis |
| IgG4 level | IgG4-related sclerosing cholangitis |
| MRCP or ERCP | Advanced biliary imaging for strictures, PSC, bile duct stones |
Step 3 — If bone source likely (GGT normal):
| Test | Purpose |
|---|---|
| 25-OH Vitamin D | Deficiency causes osteomalacia/rickets with elevated bone ALP |
| Calcium and phosphate | Low in rickets/osteomalacia; normal in Paget's |
| Bone-specific ALP (BAP) | Confirms bone origin if isoenzyme testing available |
| Parathyroid hormone (PTH) | Hyperparathyroidism causes bone remodeling and ALP rise |
| Bone scan or X-rays | Paget's disease, metastases, fractures |
COMMON ALP INTERPRETATION MISTAKES
Mistake 1: Interpreting ALP without GGT. ALP alone cannot tell you whether the source is liver or bone. GGT is the essential companion test. An ALP of 200 with normal GGT and a normal ALP of 95 with elevated GGT may both warrant attention, but for completely different reasons.
Mistake 2: Assuming a mildly elevated ALP on a CMP always reflects liver disease. Many cases of mildly elevated ALP (1–1.5× ULN) reflect bone activity, medication effects, or physiological states rather than liver disease. Jumping to liver-focused investigation without first checking GGT leads to unnecessary testing.
Mistake 3: Applying adult reference ranges to children or pregnant women. ALP values of 200–350 U/L in a growing adolescent and 150–250 U/L in the third trimester of pregnancy are entirely normal. These are not elevated results in those populations.
Mistake 4: Ignoring the trend. A single ALP of 150 U/L may be less clinically meaningful than an ALP that was 110 six months ago, then 130, then 150 — a rising trend in an otherwise normal-looking result can indicate developing disease before any value crosses the upper limit of normal.
Mistake 5: Expecting ALP to be elevated in all liver diseases. ALP is most sensitive for cholestatic disease. In hepatocellular injury, ALT and AST rise dramatically while ALP may be only mildly elevated or normal — see “Can I have liver disease with a normal ALP?” in the FAQs below.
Mistake 6: Assuming low ALP is always normal. Very low ALP — particularly in a young patient with bone fragility, premature tooth loss, or stress fractures — should prompt consideration of hypophosphatasia before attributing it to benign causes.
THE TREND MATTERS MORE THAN ANY SINGLE RESULT
A single ALP value in isolation tells an incomplete story. What matters clinically is the value in context: a stable ALP of 140 over three years is very different from an ALP that has risen from 85 to 110 to 140 to 175 over 18 months.
| ALP pattern | What it typically suggests |
|---|---|
| Consistently mildly elevated, stable over years | Often benign — chronic medication effect, mild bone activity, or lab variation |
| Rising over months | Warrants investigation regardless of whether it has yet crossed the upper limit |
| Very high, then rapidly normalizing | May reflect a transient cause (healing fracture, resolving bile duct obstruction) |
| Persistently very high (> 3× ULN) over years | More characteristic of Paget’s disease or chronic biliary disease than transient causes |
| Suddenly elevated in a patient on a new medication | Drug-induced liver injury or medication effect — timing is clinically important |
Practical re-testing guidance for a mildly elevated ALP:
| Clinical situation | Suggested repeat interval |
|---|---|
| Isolated mildly elevated ALP (< 1.5× ULN), asymptomatic, normal GGT | 3–6 months — many resolve spontaneously or with vitamin D correction |
| Mildly elevated ALP with low vitamin D identified | Recheck at 3 months after supplementation |
| ALP 1.5–2× ULN with abnormal GGT but no symptoms | 4–8 weeks alongside liver ultrasound |
| ALP > 2× ULN | Prompt workup — don’t defer 3–6 months |
| Rising trend on serial labs | Evaluate at next rise — don’t wait for the absolute value to cross a threshold |
| New medication started | Recheck at 4–8 weeks; if still elevated, medication review |
WHEN SHOULD I SEE A SPECIALIST FOR ELEVATED ALP?
Most people with a mildly elevated ALP can be evaluated and managed by their primary care provider. These situations typically warrant referral to a gastroenterologist, hepatologist, or rheumatologist:
| Situation | Specialist | Reason |
|---|---|---|
| ALP > 3× ULN with elevated GGT | Gastroenterology or hepatology | Biliary disease or significant liver pathology likely |
| ALP elevated with positive AMA | Hepatology | Primary biliary cholangitis diagnosis and management |
| ALP elevated with elevated IgG4 | Gastroenterology or rheumatology | IgG4-related sclerosing cholangitis |
| ALP elevated with suspected PSC (especially in IBD patient) | Hepatology | MRCP and specialist management |
| ALP > 3× ULN with normal GGT in older adult | Consider rheumatology or endocrinology | Paget’s disease evaluation and treatment |
| ALP persistently > 2× ULN despite vitamin D correction | Gastroenterology or endocrinology | Secondary cause unlikely to be vitamin D alone |
| Very low ALP with bone fragility or premature tooth loss | Metabolic bone specialist or endocrinology | Hypophosphatasia evaluation |
For everything else — isolated mild ALP elevation with normal GGT, no symptoms, and a plausible benign explanation — primary care monitoring with repeat labs in 3–6 months is the standard approach.
CLINICAL PEARLS
- GGT is the single most important companion test for ALP — it distinguishes liver/bile duct from bone origin more reliably than any other routine lab value
- A very high ALP (> 3× ULN) with completely normal GGT, ALT, and AST in an older adult is Paget’s disease of bone until proven otherwise — one of the most diagnostically specific patterns on a routine panel
- Bone ALP rises 2–4 weeks after a fracture and can remain elevated for 3–6 months during healing — a fracture history is always worth asking about
- In acute hepatitis (viral or toxic), ALT and AST rise far more dramatically than ALP — an ALP that’s only 1.5× ULN while ALT is 10× ULN points toward hepatocellular injury, not bile duct obstruction
- Low ALP in Wilson’s disease with acute liver failure is a recognized and important pattern — virtually the only condition where ALP falls rather than rises in the context of acute liver failure
- Primary biliary cholangitis (PBC) classically presents with ALP elevated out of proportion to ALT/AST — if this pattern is seen in a middle-aged woman with fatigue and pruritus, anti-mitochondrial antibody (AMA) testing should be added
Alkaline Phosphatase (ALP)
Alkaline Phosphatase (ALP)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →Beyond Alkaline Phosphatase (ALP) — 10,000+ markers explained
One Alkaline Phosphatase (ALP) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Frequently Asked Questions
What does ALP have to do with vitamin D?
Vitamin D deficiency is one of the most common and most overlooked causes of mildly to moderately elevated ALP. Here’s the mechanism: vitamin D is essential for normal bone mineralization. When vitamin D is insufficient, the body struggles to properly incorporate calcium and phosphate into bone. The body responds by increasing osteoblast (bone-forming cell) activity in an attempt to compensate — and osteoblasts produce bone isoenzyme ALP. The result is an elevated serum ALP despite no liver disease being present. This is why 25-OH Vitamin D is almost always included in the initial workup of an unexplained elevated ALP with normal GGT. In many cases, correcting vitamin D deficiency with supplementation brings ALP back to normal within 3–6 months — making it one of the more satisfying reversible causes to identify and treat.
Why is my ALP elevated but all other liver tests are normal?
This is one of the most common clinical situations with ALP — and one of the most reassuring. An isolated elevated ALP with completely normal GGT, ALT, AST, and bilirubin almost always means the ALP is not coming from the liver at all. The most common explanations, in rough order of frequency, are: vitamin D deficiency causing increased bone turnover (check 25-OH vitamin D), a healing bone fracture (even a minor one the patient may not have connected to their bloodwork), Paget’s disease of bone in older adults (usually incidental and asymptomatic), the physiological bone growth ALP in an adolescent or young adult, bone metastases in a patient with a cancer history, or a transient post-meal elevation from intestinal ALP in blood types B or O. If GGT is truly normal, no further liver-specific investigation is usually needed — the workup redirects entirely to bone.
Can high ALP return to normal?
Yes — whether and how quickly ALP normalizes depends entirely on the cause. ALP from a healing fracture typically returns to normal within 3–6 months as healing completes — it peaks around 2–4 weeks post-fracture then gradually declines. Medication-induced elevation usually resolves within 2–8 weeks of stopping the offending drug. Vitamin D deficiency-related elevation typically normalizes within 3–6 months of adequate supplementation (recheck 25-OH Vitamin D and ALP together at the 3-month mark). In fatty liver disease, meaningful ALP improvement typically requires 6–12 months of sustained metabolic improvement. Primary biliary cholangitis treated with ursodiol typically shows ALP response within 3–6 months; incomplete response after 12 months is a criterion for escalating therapy. Treating bile duct obstruction typically produces rapid ALP improvement within 1–2 weeks as obstruction is relieved. Paget’s disease typically responds to a single course of bisphosphonate (e.g., zoledronic acid) with ALP reduction of 50–80% within 3–6 months. Conditions that have caused irreversible liver damage (advanced cirrhosis) may not fully normalize.
My ALP is 250, my GGT is also high, but my ALT and AST are normal — what does this mean?
This is the classic biochemical signature of cholestatic liver disease — bile duct rather than liver cell injury. The main causes: primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), bile duct obstruction from gallstones or a stricture, and drug-induced cholestasis. Liver ultrasound is the first-line imaging step; if normal, anti-mitochondrial antibody (AMA) testing for PBC and IgG4 levels for IgG4-related sclerosing cholangitis are typically next.
My ALP is 180 and my GGT is normal — what does that mean?
High ALP with normal GGT essentially rules out a liver or bile duct source. The most likely explanations in an adult: vitamin D deficiency causing increased bone turnover (check 25-OH vitamin D), Paget’s disease in older adults, a healing fracture, bone metastases in patients with a cancer history, or a transient post-meal elevation in blood types B or O. Checking 25-OH vitamin D is the most common practical first step for this pattern.
Can I have liver disease with a normal ALP?
Yes — and this is an important point that’s often missed. ALP is most sensitive for cholestatic liver disease (bile duct obstruction, primary biliary cholangitis). In hepatocellular disease — where liver cells themselves are injured, as in acute viral hepatitis, autoimmune hepatitis, or toxic hepatitis — ALT and AST rise dramatically while ALP may be only mildly elevated or even entirely normal. Someone with acute hepatitis A and an ALT of 800 U/L might have an ALP of just 90 U/L. The corollary: if ALP is the most elevated enzyme on a liver panel (with ALT and AST relatively less affected), the disease is more likely cholestatic or biliary than hepatocellular.
What does it mean if my ALP is high?
A high alkaline phosphatase (ALP) most commonly reflects increased activity in the liver, bile ducts, or bones. The most important next step is checking GGT (gamma-glutamyl transferase): if GGT is also elevated, the excess ALP is almost certainly coming from the liver or bile ducts; if GGT is normal, the ALP is more likely from bone. Mild elevation (up to 1.5–2× the upper limit of normal) is extremely common and often explained by benign causes — fatty liver, vitamin D deficiency, medications, healing bone, or a post-meal artifact. More significant elevation warrants a clinical evaluation to identify the specific cause.
My ALP is 130 — should I be worried?
An ALP of 130 U/L is mildly above the upper limit at LabCorp (121 U/L) but within the normal range at some other labs. Whether it's clinically meaningful depends on context. If GGT, ALT, and AST are all normal, the most likely explanations are a lab-specific range difference, minor bone activity, or a post-meal artifact. If GGT is also elevated, it suggests a liver or bile duct origin and warrants follow-up. An isolated, mildly elevated ALP on a routine lab without symptoms and with normal GGT/ALT/AST is often simply repeated in 3–6 months to confirm it's not rising.
My ALP is 200 — what does that mean?
An ALP of 200 U/L is moderately elevated — approximately 1.7× the upper limit of normal at most US labs. This level is unlikely to be explained by lab variation or a post-meal artifact alone. The clinical priority is determining whether it's from the liver/bile ducts or from bone. Checking GGT, ALT, and AST together with a clinical review of symptoms, medications, alcohol intake, and recent bone events (fractures, bone pain) is the appropriate next step.
What does high ALP with normal GGT mean?
High ALP with normal GGT (gamma-glutamyl transferase) strongly suggests the excess ALP is coming from bone rather than the liver or bile ducts. GGT is produced by liver and bile duct cells but not by bone, so a normal GGT almost rules out a hepatic or biliary source of ALP elevation. Common bone-related causes include Paget's disease, vitamin D deficiency with osteomalacia, a healing fracture, bone metastases, or physiological bone growth in children and adolescents. This combination is also normal during the third trimester of pregnancy (placental ALP, not bone) and transiently after a fatty meal in certain blood types.
My ALP is low — should I be worried?
A mildly low ALP (just below the lower limit, typically around 30–44 U/L depending on the lab) in an otherwise healthy adult is often not clinically significant — particularly if other markers are normal and there are no symptoms. The most common explanations are nutritional: zinc or magnesium deficiency (both are direct cofactors for ALP enzyme activity), protein-energy malnutrition, or hypothyroidism. These are all correctable. The situations worth taking more seriously are: a very low ALP (approaching zero or undetectable) in anyone — which raises concern for hypophosphatasia; a low ALP in a young patient with acute liver failure and jaundice — which is a recognized pattern for Wilson’s disease; and a low ALP in someone with celiac disease, B12 deficiency, or other malabsorptive states. For most adults who see a mildly low ALP flagged on a routine panel, checking TSH, zinc, magnesium, and B12 is a reasonable first step before concluding the result is simply a lab variation.
What does low ALP mean?
Low ALP (below approximately 44 U/L) most often reflects a nutritional deficiency — particularly zinc, magnesium, or protein — or hypothyroidism, any of which can reduce ALP enzyme activity or production. Celiac disease with malabsorption and vitamin B12 deficiency are other documented causes. Hypophosphatasia is a rare genetic condition causing severely low ALP and is important to recognize because it affects bone health and has specific treatment implications. A notable exception: very low ALP in a young patient with acute liver failure is a recognized warning sign for Wilson's disease, where ALP paradoxically falls rather than rising as it does in most other forms of liver failure.
Does ALP level indicate cancer?
ALP can be elevated in certain cancers, but elevated ALP does not diagnose cancer. The most common cancers associated with elevated ALP are liver metastases (from colorectal, breast, lung, and other primaries), primary liver cancer (hepatocellular carcinoma), bone metastases (from breast, prostate, lung, and other primaries), and Paget's disease (which is benign but can occasionally be associated with osteosarcoma transformation). In each of these cases, ALP is elevated alongside other clinical findings — imaging, cancer markers, and biopsy where needed — not as a standalone diagnostic. A mildly elevated ALP on a routine panel in an otherwise healthy person is very unlikely to reflect cancer.
Qu'est-ce que la phosphatase alcaline élevée? (French)
La phosphatase alcaline (PAL ou ALP) est une enzyme produite principalement par le foie, les voies biliaires et les os. Un taux élevé peut refléter une maladie hépatique, une obstruction des voies biliaires, ou une pathologie osseuse. Le test le plus utile pour distinguer ces sources est la GGT (gamma-glutamyl transférase) : si la GGT est également élevée, la source est probablement hépatique ou biliaire ; si la GGT est normale, la source est plus probablement osseuse. Une élévation modérée de la PAL est fréquente et souvent bénigne.
Alkalen fosfataz yüksek ne anlama gelir? (Turkish)
Alkalen fosfataz (ALP), karaciğer, safra kanalları ve kemikler tarafından üretilen bir enzimdir. Yüksek ALP, genellikle bu dokulardan birinin stres altında olduğunu gösterir. En önemli yardımcı test GGT’dir: GGT de yüksekse kaynak büyuk olasılıkla karaciğer veya safra kanallarıdır; GGT normalse kaynak kemik olabilir. Hafif yükseklik (1–1,5 kat normal değer) çoğu zaman ilaç etkisi, vitamin D eksikliği veya kemik aktivitesi ile açıklanabilir.
¿Qué significa la fosfatasa alcalina alta? (Spanish)
La fosfatasa alcalina (ALP o FAL) es una enzima producida por el hígado, los conductos biliares y los huesos. Un nivel elevado puede deberse a enfermedades hepáticas, obstrucción biliar, o condiciones óseas como la deficiencia de vitamina D, la enfermedad de Paget, o fracturas en proceso de curación. También es normal durante el crecimiento en niños y en el tercer trimestre del embarazo. La clave para identificar el origen es medir la GGT: si está elevada, el exceso de ALP proviene del hígado; si es normal, probablemente proviene de los huesos.
ما هو الفسفاتاز القلوي المرتفع؟ (Arabic)
الفسفاتاز القلوي (ALP) هو إنزيم ينتجه الكبد والعظام والقنوات الصفراوية. عندما يرتفع مستواه في الدم، يكون السبب في الغالب أحد الأمرين: مشكلة في الكبد أو القنوات الصفراوية، أو زيادة نشاط العظام (كنمو الأطفال أو أمراض العظام). الخطوة الأهم هي قياس إنزيم GGT: إذا كان مرتفعاً، فالمشكلة على الأرجح في الكبد؛ وإذا كان طبيعياً، فالمصدر غالباً العظام.
Clinical Sources & References
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
-
Serum Alkaline Phosphatase: Clinical and Laboratory Perspectives
-
Alkaline phosphatase: an overview
-
Alkaline phosphatase
Article Review Log
Last reviewed
July 1, 2026
Originally published
July 1, 2026
Reviewed by
HealthMatters Editorial Team
Written by
Healthmatters Editorial Team